A Study of SL-325 in Crohn's Disease Patients

NCT07753850 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

232

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: SL-325
DRUG: Placebo

Sponsor

Shattuck Labs, Inc.